Who / What
Cystic fibrosis (CF) is a genetic disorder inherited in an autosomal recessive manner that primarily affects the lungs. It impairs the normal clearance of mucus from the lungs, leading to bacterial colonization and infections. The condition also impacts other organs such as the pancreas, liver, kidneys, and intestines.
Background & History
Cystic fibrosis was first clearly described in medical literature in the 1930s, with its genetic basis understood later. The inheritance pattern was identified as autosomal recessive, meaning both parents must carry a defective gene for a child to be affected. Key milestones include the identification of the CFTR gene in 1989, which advanced understanding and treatment.
Why Notable
Cystic fibrosis is notable as a significant cause of chronic illness and reduced life expectancy, particularly in populations of European descent. Research into CF has led to breakthroughs in genetics and personalized medicine, such as CFTR modulator therapies. It remains a focus of public health efforts due to its impact on quality of life and healthcare systems.
In the News
Recent advances in treatment, including highly effective modulator therapies, have dramatically improved outcomes for many CF patients. Ongoing research aims to develop therapies for all CF mutations and address complications like antibiotic-resistant infections. Increased newborn screening has improved early diagnosis and intervention.
